Researchers have confirmed that therapeutic ultrasound can be used as a male contraceptive, providing up to 2.5 months of protection in rats with two 15-minute sessions. The method was initially overlooked for decades due to concerns over its effectiveness, but new evidence suggests it may offer an alternative to existing options.
Researchers at the University of North Carolina have developed a male contraceptive method using therapeutic ultrasound, which has shown promising results in animal studies. The method involves 15 minutes of ultrasound treatment for six months of contraception, with permanent sterilization achieved with no vasectomy needed.
Researchers have made significant breakthroughs in developing new male contraceptives, including a hormone-based regimen that worked in 90% of men, a vasectomy alternative with high success rates, and a vitamin A-blocking drug that showed no health effects. These advancements offer hope for men seeking reliable birth control options.
Researchers at the NIH conference present advances in male contraception, including a non-hormonal pill and a testosterone-like treatment. These developments aim to provide men with more control over their fertility, offering an alternative to existing methods like condoms and vasectomy.
Researchers have made a breakthrough with non-hormonal compound Adjudin, which has shown safety and effectiveness in rats when administered as an attachment to a modified hormone targeting the testes. However, its delivery system needs improvement, and it remains to be seen whether it will work as well in humans as in rodents.
The IVD is a long-term contraceptive designed as an alternative to vasectomy, blocking sperm by plugging the vas deferens. The new device aims to be more appealing than traditional methods, but reversibility studies in men are still unknown.
Researchers received FDA approval for a nonhormonal contraceptive device that blocks sperm in the vas deferens, aiming to provide a long-term and reversible method. The Intra Vas Device has shown effectiveness in preliminary studies, with men citing benefits such as avoiding hormonal side effects.